{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:12:09Z","timestamp":1790507529828,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.canlet.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T22:01:24Z","timestamp":1379109684000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides"],"prefix":"10.1016","volume":"343","author":[{"given":"Neelu","family":"Puri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Mulnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrianne","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra N.","family":"Iness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Salgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.09.010_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.seminoncol.2011.01.012","article-title":"Personalized treatment of lung cancer","volume":"38","author":"Salgia","year":"2011","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2013.09.010_b0010","first-page":"53","article-title":"Clinical implications of p53 mutations in lung cancer","volume":"75","author":"Campling","year":"2003","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.canlet.2013.09.010_b0015","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1021\/ja017308q","article-title":"Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex","volume":"124","author":"Kim","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2013.09.010_b0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/mol.60.5.981","article-title":"Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes","volume":"60","author":"Gowan","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2013.09.010_b0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1124\/mol.61.5.1154","article-title":"A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity","volume":"61","author":"Gowan","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2013.09.010_b0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jcb.21635","article-title":"Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells","volume":"104","author":"Dikmen","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2013.09.010_b0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ctrv.2012.06.007","article-title":"Novel anticancer therapeutics targeting telomerase","volume":"39","author":"Ruden","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2013.09.010_b0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jnci\/djq145","article-title":"Telomerase-based therapies emerging slowly","volume":"102","author":"Brower","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2013.09.010_b0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CAD.0b013e3282f5d4c2","article-title":"Telomerase inhibitors and \u2018T-oligo\u2019 as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity","volume":"19","author":"Rankin","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2013.09.010_b0050","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.283.5406.1321","article-title":"P53- and ATM-dependent apoptosis induced by telomeres lacking TRF2","volume":"283","author":"Karlseder","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2013.09.010_b0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/excr.2002.5531","article-title":"Induction of apoptosis by telomere 3\u2032 overhang-specific DNA","volume":"276","author":"Eller","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0060","doi-asserted-by":"crossref","first-page":"12627","DOI":"10.1073\/pnas.94.23.12627","article-title":"Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response","volume":"94","author":"Eller","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.010_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexcr.2004.08.019","article-title":"Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides","volume":"301","author":"Li","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1096\/fj.04-1774com","article-title":"Telomere-based DNA damage responses: a new approach to melanoma","volume":"18","author":"Puri","year":"2004","journal-title":"Faseb J."},{"key":"10.1016\/j.canlet.2013.09.010_b0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1096\/fj.02-0197com","article-title":"Induction of a p95\/Nbs1-mediated S phase checkpoint by telomere 3\u2032 overhang specific DNA","volume":"17","author":"Eller","year":"2003","journal-title":"Faseb J."},{"key":"10.1016\/j.canlet.2013.09.010_b0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1073\/pnas.0235444100","article-title":"Evidence that exposure of the telomere 3\u2032 overhang sequence induces senescence","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.010_b0085","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jcp.22997","article-title":"Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells","volume":"227","author":"Rankin","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2013.09.010_b0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdermsci.2009.08.008","article-title":"Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage","volume":"56","author":"Lee","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.canlet.2013.09.010_b0095","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr1646","article-title":"Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells","volume":"9","author":"Yaar","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/oli.2010.0259","article-title":"T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells","volume":"21","author":"Sarkar","year":"2011","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.canlet.2013.09.010_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/oli.2009.0179","article-title":"T-oligo induces apoptosis in advanced prostate cancer cells","volume":"19","author":"Gnanasekar","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.canlet.2013.09.010_b0110","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1096\/fj.06-6941com","article-title":"Telomere 3\u2032 overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells","volume":"21","author":"Aoki","year":"2007","journal-title":"Faseb J."},{"key":"10.1016\/j.canlet.2013.09.010_b0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.23946","article-title":"Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential","volume":"124","author":"Longe","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2013.09.010_b0120","doi-asserted-by":"crossref","first-page":"928628","DOI":"10.1155\/2010\/928628","article-title":"Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides","volume":"2010","author":"Coleman","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.canlet.2013.09.010_b0125","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.1815309","article-title":"The combined status of ATM and p53 link tumor development with therapeutic response","volume":"23","author":"Jiang","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2013.09.010_b0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2011.06.012","article-title":"Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop","volume":"43","author":"Oliver","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2013.09.010_b0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00280-010-1434-6","article-title":"P53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma","volume":"67","author":"Shao","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2013.09.010_b0140","first-page":"1145","article-title":"Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines","volume":"9","author":"Ling","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0145","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.gt.3301592","article-title":"Cell cycle arrest is sufficient for p53-mediated tumor regression","volume":"8","author":"Dubrez","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2013.09.010_b0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.onc.1206929","article-title":"P53 protein variants: structural and functional similarities with p63 and p73 isoforms","volume":"23","author":"Courtois","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.010_b0155","first-page":"2340","article-title":"Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions","volume":"52","author":"Takahashi","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0160","doi-asserted-by":"crossref","first-page":"19501","DOI":"10.1074\/jbc.M511224200","article-title":"Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta Lyn kinase, and matrix metalloproteinases","volume":"281","author":"Zhao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.09.010_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.44372","article-title":"Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer","volume":"7","author":"Puri","year":"2008","journal-title":"J. Carcinog."},{"key":"10.1016\/j.canlet.2013.09.010_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-59745-361-5_3","article-title":"Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay","volume":"371","author":"Itahana","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2013.09.010_b0175","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2013.09.010_b0180","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1073\/pnas.1009010107","article-title":"Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.010_b0185","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.010_b0190","first-page":"113","article-title":"E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2","volume":"9","author":"Kowalik","year":"1998","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.canlet.2013.09.010_b0195","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/sj.onc.1208474","article-title":"Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities","volume":"24","author":"He","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.010_b0200","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/bcr2639","article-title":"Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment","volume":"12","author":"Weng","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0205","first-page":"3761","article-title":"A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents","volume":"59","author":"Chang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/34675","article-title":"The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control","volume":"391","author":"Garkavtsev","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2013.09.010_b0215","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.bjc.6603448","article-title":"Upregulation of p27 and its inhibition of CDK2\/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21","volume":"95","author":"He","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2013.09.010_b0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2013.09.010_b0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10520290802451085","article-title":"Immunohistochemistry in the evaluation of neovascularization in tumor xenografts","volume":"83","author":"Wang","year":"2008","journal-title":"Biotechnol. Histochem."},{"key":"10.1016\/j.canlet.2013.09.010_b0230","first-page":"4287","article-title":"Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro","volume":"6","author":"Lund","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0235","doi-asserted-by":"crossref","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.canlet.2013.09.010_b0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/nat.2012.0401","article-title":"Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis","volume":"23","author":"Sarkar","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.canlet.2013.09.010_b0245","doi-asserted-by":"crossref","first-page":"761","DOI":"10.18632\/oncotarget.1047","article-title":"Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma","volume":"4","author":"Pitman","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2013.09.010_b0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/drup.2001.0213","article-title":"If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells","volume":"4","author":"Roninson","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.canlet.2013.09.010_b0255","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1083\/jcb.147.4.823","article-title":"Comparative analysis of p73 and p53 regulation and effector functions","volume":"147","author":"Fang","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2013.09.010_b0265","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc2718","article-title":"P53 and E2f: partners in life and death","volume":"9","author":"Polager","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2013.09.010_b0270","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1074\/jbc.M307469200","article-title":"P73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation","volume":"279","author":"Melino","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.09.010_b0275","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1038\/sj.onc.1204748","article-title":"P53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor","volume":"20","author":"Jung","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.010_b0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-62703-239-1_3","article-title":"Senescence regulation by the p53 protein family","volume":"965","author":"Qian","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2013.09.010_b0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1023565227808","article-title":"Toxicity patterns of cytotoxic drugs","volume":"21","author":"Chatelut","year":"2003","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.canlet.2013.09.010_b0290","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1634\/theoncologist.12-12-1443","article-title":"Review: side effects of approved molecular targeted therapies in solid cancers","volume":"12","author":"Widakowich","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2013.09.010_b0295","first-page":"2287","article-title":"Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene","volume":"54","author":"Fujiwara","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.010_b0300","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2013.09.010_b0305","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00109-007-0221-2","article-title":"Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome","volume":"85","author":"Teodoro","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.canlet.2013.09.010_b0310","first-page":"178","article-title":"Regulation of tumor angiogenesis by thrombospondin-1","volume":"1765","author":"Ren","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2013.09.010_b0315","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/sj.onc.1203672","article-title":"Expression of the vascular endothelial growth factor gene is inhibited by p73","volume":"19","author":"Salimath","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.010_b0320","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1038\/sj.onc.1204896","article-title":"P73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis","volume":"20","author":"Vikhanskaya","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.010_b0325","doi-asserted-by":"crossref","first-page":"e13442","DOI":"10.1371\/journal.pone.0013442","article-title":"E2F\u20131 directly regulates thrombospondin 1 expression","volume":"5","author":"Ji","year":"2010","journal-title":"PLoS One"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513006630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513006630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T23:20:00Z","timestamp":1563924000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513006630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0304383513006630"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.09.010","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}